创伤后应激障碍可扩展生物标志物发现:健康系统生物库的基因组与表型三角验证
Biomarkers can potentially improve the diagnosis, monitoring, and treatment of posttraumatic stress disorder (PTSD). However, PTSD biomarkers that are scalable and easily integrated into real-world clinical settings have not been identified.…
要点
- 孟德尔随机化提示PTSD易感性可能单向影响肝脏、心血管代谢和血液标志物。
- 三角验证方法有助于发现可扩展且临床相关的PTSD生物标志物。
核心结论
- 三角验证方法可揭示PTSD可扩展且临床相关的生物标志物。
研究设计与样本
- 纳入23,743名欧洲血统参与者,来自嵌套的MGB Biobank研究。
主要发现
- 两样本孟德尔随机化分析提示PTSD易感性对肝脏标志物(白蛋白和总胆红素降低)、心血管代谢标志物(HDL胆固醇降低和VLDL胆固醇升高)和血液标志物(平均血小板体积降低)存在潜在单向因果效应。
关键数值与推荐
- 第一暴露为PTSD多基因风险评分,使用最大欧洲血统全基因组关联研究通过贝叶斯多基因评分方法计算。
- 第二暴露为PTSD临床诊断,由纵向电子健康记录中两次或以上PTSD相关诊断代码确定。
- 主要结局为241项具有非零h2SNP估计的实验室特征的中位数实验室值经逆正态分位数转换。
临床怎么用
- 提示可借助健康系统生物库和电子健康记录整合基因组与实验室数据,发现可扩展的PTSD生物标志物。
- 肝脏、心血管代谢和血液标志物可能作为PTSD相关生物学变化的候选指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Biomarkers can potentially improve the diagnosis, monitoring, and treatment of posttraumatic stress disorder (PTSD). However, PTSD biomarkers that are scalable and easily integrated into real-world clinical settings have not been identified. The analysis was conducted between June to November 2024 using genomic samples and laboratory test results recorded in the Mass General Brigham (MGB) Health System. The analysis included 23,743 European ancestry participants from the nested MGB Biobank study. The first exposure was polygenic risk score (PRS) for PTSD, calculated using the largest available European ancestry genome-wide association study (GWAS), employing a Bayesian polygenic scoring method. The second exposure was a clinical diagnosis of PTSD, determined by the presence of two or more instances of PTSD-related diagnostic codes in the longitudinal electronic health records (EHR). The primary outcomes were the inverse normal quantile transformed, median lab values of 241 laboratory traits with non-zero h2SNP estimates. Sixteen unique laboratory traits across the cardiometabolic, hematologic, hepatic, and immune systems were implicated in both genomic and phenotypic lab-wide association scans (LabWAS). Two-sample Mendelian randomization analyses provided evidence of potential unidirectional causal effects of PTSD liability on hepatic (decreased albumin and total bilirubin), cardiometabolic (decreased HDL cholesterol and increased VLDL cholesterol), and hematologic (decreased mean platelet volume) markers. These findings demonstrate the potential of a triangulation approach to uncover scalable and clinically relevant biomarkers for PTSD.
引用
- Lee YH, Zhang Y, Espinosa Dice AL, et al. Towards scalable biomarker discovery in posttraumatic stress disorder: triangulating genomic and phenotypic evidence from a health system biobank. Mol Psychiatry. 2026. PMID: 41946832. doi:10.1038/s41380-026-03553-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。